Researchers from the University of Oxford in collaboration with an intellectual property law firm have revealed that the NHS may be able to recoup over half a billion pounds from Pfizer if its Supreme Court patent appeal is unsuccessful more

27 Feb 2018 15:46 News

A drug that was believed to be a promising new therapeutic option for suffers of Alzheimer’s (idalopirdine) — from the Danish pharma company, Lundbeck — has failed to show clinical benefit in three randomised trials. more

11 Jan 2018 12:41 News

A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. more

9 Jan 2018 10:53 News

A new government ruling, allowing the erectile dysfunction (ED) drug Sildenafil to be sold without a prescription, could mean drug prices fall further. more

29 Nov 2017 16:24 News

The US Food and Drug Administration (FDA) has approved Sutent (sunitinib malate) for the adjuvant treatment for adult patients at a high risk of kidney cancer returning after nephrectomy. more

20 Nov 2017 14:45 News

Two life-extending drugs will now be available to breast cancer patients on the NHS after price negotiations lead the National Institute for Health and Care Excellence (NICE) to approve them. more

16 Nov 2017 12:32 News

Pfizer has released a statement on its position concerning its consumer healthcare business, revealing that it will be considering a range of strategic alternatives as part of its efforts to best serve patients and maximise value for its shareholders more

18 Oct 2017 12:13 News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

8 Sep 2017 15:00 News

Pfizer’s treatment for adults with newly diagnosed acute myeloid leukaemia whose tumors express the CD33 antigen (CD33-positive AML), Mylotarg (gemtuzumab ozogamicin), has been approved by the US Food and Drug Administration (FDA). more

4 Sep 2017 12:33 News

The Alliance Foundation Trials (AFT) — in conjunction with Pfizer and six international cancer research groups — has launched a randomised open-label Phase III clinical study, PATINA, to evaluate a combination therapy for breast cancer. more

23 Aug 2017 12:01 News

The US Food and Drug Administration (FDA) has approved a targeted therapy, Besponsa (inotuzumab ozogamicin), for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). more

21 Aug 2017 14:00 News

Contract development and manufacturing organisation (CDMO), Avara Pharmaceutical Services, has acquired the Italian sterile manufacturing facility in an agreement with Pfizer. more

14 Aug 2017 13:42 News

Three healthtech start-ups have been selected by biopharmaceutical company Pfizer to help get their technologies adopted onto the NHS. more

7 Jul 2017 11:37 News

Pfizer has provided an update on its biologics licence application (BLA) for its proposed epoetin alfa biosimilar after receiving a complete response letter (CRL) from the US Food and Drug Administration (FDA). more

26 Jun 2017 15:09 News

Astellas Pharma and Pfizer have announced an amendment to the clinical research protocol for the Phase III PROSPER trial evaluating XTANDI (enzalutamide) in patients with non-metastatic (M0) castration-resistant prostate cancer (CRPC) more

12 Jun 2017 10:45 News

A device that allows women to self-administer a long-acting contraceptive has been reduced in price. The Sayana Press has reduced in price from $1 to $0.85 per dose. more

10 May 2017 11:04 News

Pfizer has launched a website and app to help fight antimicrobial resistance. more

9 May 2017 14:44 News

Pfizer has announced it will provide its breast cancer drug, palbociclib — which has been provisionally rejected by NICE for routine use as a result of cost — to the NHS for free for up to five months until a final decision by NICE is made. more

9 May 2017 11:20 News

A collaboration agreement has been announced by Domain Therapeutics and Pfizer, which is aimed at assessing the impact of mutations on different signalling pathways engaged by GPCRs. more

26 Apr 2017 00:00 News

Pfizer, GEA and G-Con Manufacturing team up to produce a portable manufacturing facility for oral solid dosage forms. more

19 Jan 2017 11:40 News